News & Updates
Filter by Specialty:
Show Multimedia Only

Inhaled amikacin cuts VAP burden in mechanically ventilated patients
16 Jan 2024
byAudrey Abella
In critically ill patients who have been on invasive mechanical ventilation (IMV) for at least 3 days, a subsequent 3-day course of preventive inhaled amikacin reduced the burden of ventilator-associated pneumonia (VAP) during 28 days of follow-up, findings from the AMIKINHAL trial have shown.
Inhaled amikacin cuts VAP burden in mechanically ventilated patients
16 Jan 2024
mRNA boosters protect cancer patients against adverse COVID-19 outcomes
08 Jan 2024
byAudrey Abella
A prospective study from Singapore provides evidence of the clinical effectiveness of mRNA-based vaccines against COVID-19 in individuals with cancer.